Complex Generics Portfolio

About Torrent Pharmaceuticals

Torrent Pharmaceuticals is a mission-driven, revenue-generating leader in the global branded generics market, focused on improving patient access to high-quality, complex medicines. Its core strategy of therapeutic area specialization and geographic diversification has yielded market leadership in India, Brazil, and Germany, supported by a robust manufacturing and R&D infrastructure. The company is executing a growth strategy centered on expanding its portfolio of complex generics, biosimilars, and consumer healthcare brands while maintaining a strong commitment to sustainability and ESG principles.

About Mankind Pharma

Mankind Pharma is a dominant Indian pharmaceutical player with a mission to deliver affordable and accessible healthcare across the nation. Founded in 1995, it has achieved market leadership through deep penetration of underserved rural and semi-urban markets, supported by a company-owned distribution infrastructure. Its strategy is built on a diversified business model spanning formulations, consumer healthcare, APIs, and agritech, backed by significant R&D capabilities and manufacturing scale. The company is publicly traded and is recognized for its operational excellence and commitment to serving 'Bharat'.

About Alembic Pharmaceuticals

Alembic Pharmaceuticals' mission is to accelerate access to quality, affordable medicines globally through a vertically integrated model spanning API synthesis to finished dosage forms. The company has achieved significant scale, with over $250M in annual US frontend sales, a pipeline of 252 ANDA filings, and a strategic foray into proprietary drug discovery with three disclosed NCE candidates. Its strategy balances cash-generating generics businesses with disciplined R&D investments in complex generics and novel therapeutics to drive long-term, high-margin growth.

Therapeutic Areas